healthy transitions: maintaining mental health though the menopausal transition
DESCRIPTION
Healthy Transitions: Maintaining Mental Health though the Menopausal Transition. Katherine L. Wisner, M.D., M.S. Norman and Helen Asher Professor of Psychiatry and Obstetrics and Gynecology Director, Asher Center for Research and Treatment of Depressive Disorders - PowerPoint PPT PresentationTRANSCRIPT
11
Healthy Transitions: Maintaining Mental Health
though the Menopausal Transition
Katherine L. Wisner, M.D., M.S.
Norman and Helen Asher Professor of Psychiatry and Obstetrics and Gynecology
Director, Asher Center for Research and Treatment of Depressive Disorders
Member, Institute for Women’s Health Research
Feinberg School of Medicine
Northwestern University, Chicago IL
22
The Longitudinal Laboratory of Women’s Lives
MenarcheMenarchePremenstruumPremenstruum
PregnancyPregnancyPostpartumPostpartumMenopauseMenopause
Menstrual Cycle ChangesMenstrual Cycle Changes
44
STRAW +10 Stages(Stages of Reproductive Aging Workshop)
Menopause 2012. 19(4): 387-95.
Challenges for Midlife Women
Average age 51 yearsAverage age 51 years Systemic Problems related to estrogen decreaseSystemic Problems related to estrogen decrease
• Hot flushesHot flushes• Insomnia, Irritability, Depression, Mood labilityInsomnia, Irritability, Depression, Mood lability• Memory changesMemory changes• Bone lossBone loss• Cardiovascular healthCardiovascular health
Focal Problems Focal Problems • Vaginal drynessVaginal dryness• Vaginal atrophyVaginal atrophy• Pain with intercoursePain with intercourse• Urinary problemsUrinary problems
66
Challenges for Midlife Women
During the menopausal transition, depression affects between 12-23% of women aged 40-59 years
>43 million women (14% of US population) who have among the highest rates of depression of any demographic
The majority of women do not develop depression (“empty nest syndrome, involutional melancholia”) !!
77
MenopauseMenopause Risk for depression especially women with previous Risk for depression especially women with previous
episodesepisodesEstrogen withdrawal theoryEstrogen withdrawal theory Estrogen enhances serotonergic and noradrenergic Estrogen enhances serotonergic and noradrenergic
transmission transmission Domino theoryDomino theory Somatic symptoms, especially sleep disturbance, Somatic symptoms, especially sleep disturbance,
anxiety, sexual dysfunction, create risk for anxiety, sexual dysfunction, create risk for depression as a down-line effectdepression as a down-line effect
Life stage perspectiveLife stage perspective Changing family or professional roles, interpersonal Changing family or professional roles, interpersonal
losses, aging and physical illnesslosses, aging and physical illness
88
EpidemiologyMajor Depression-
Major Public Health Impact
• Depression is common. • Globally, >350 million people of all ages suffer. • Depression is the leading cause of disability
worldwide, and a major contributor to the global burden of disease.
• Twice as many women are affected as men.• Lifetime, Female (F)=21%; Male (M)=12%• Annual, F=13%, M=8%• There are effective treatments for depression!
www.who.int/mediacentre/factsheets/fs369/en/index.html
99
Gender Differences in the Prevalence of Major Depression
Women have twice the rate relative to menWomen have twice the rate relative to men
Kessler et al (1993) Journal of Affective Disorders
1010
Clinical Presentation: Major Depression
For two weeks, most of the day nearly For two weeks, most of the day nearly every day, 5 of these (one must be mood or every day, 5 of these (one must be mood or interest):interest):
Depressed moodDepressed mood Diminished interest/pleasureDiminished interest/pleasure Weight loss/ gain unrelated to dietingWeight loss/ gain unrelated to dieting Insomnia/ hypersomniaInsomnia/ hypersomnia Psychomotor agitation/ retardationPsychomotor agitation/ retardation Fatigue or loss of energyFatigue or loss of energy Feelings of worthlessness/guiltFeelings of worthlessness/guilt Diminished ability to concentrateDiminished ability to concentrate Recurrent thoughts of deathRecurrent thoughts of deathNIMH--MDD in Women brochure for patients: NIMH--MDD in Women brochure for patients: www.nimh.nih.gov/health/publications/women-and-www.nimh.nih.gov/health/publications/women-and-depression-discovering-hope/index.shtmldepression-discovering-hope/index.shtml
1111
Pathophysiology:Pathophysiology: Individual and Social FactorsIndividual and Social Factors
Personality traits (passive, unassertive; ruminative) Personality traits (passive, unassertive; ruminative) associated with female gender and depression. associated with female gender and depression.
Close interpersonal relationships are relatively Close interpersonal relationships are relatively more important to women than men; disruptions in more important to women than men; disruptions in relationships are particularly stressful.relationships are particularly stressful.
Women more likely ruminate about interpersonal Women more likely ruminate about interpersonal difficulties and conflicts difficulties and conflicts
Less resource access: Full-time working women Less resource access: Full-time working women earn $0.77 per $1 a man earns: less money for earn $0.77 per $1 a man earns: less money for needs of their families, more women living in needs of their families, more women living in poverty, and far less savings for retirement.poverty, and far less savings for retirement.
1212
Pathophysiology:Pathophysiology: Life Stress and TraumaLife Stress and Trauma
Women experience more stressors more frequently Women experience more stressors more frequently than men. than men. • Childhood sexual abuse (6%-33%)Childhood sexual abuse (6%-33%)• Adult sexual assault (estimate 15%)Adult sexual assault (estimate 15%)• Male partner violence (WHO, 15%-71% across Male partner violence (WHO, 15%-71% across
10 countries)10 countries) Women are more likely to react to stressors with Women are more likely to react to stressors with
depression.depression. Frequent stressors and stress reactivity perpetuate Frequent stressors and stress reactivity perpetuate
and kindle womenand kindle women’’s vulnerability to depression over s vulnerability to depression over time.time.
(Nolen-Hoeksema, S. -Wye River, Oct. 2000)(Nolen-Hoeksema, S. -Wye River, Oct. 2000)
1313
Pathophysiology Biological DifferencesBiological Differences
Depressive illnesses are brain disorders Depressive illnesses are brain disorders Neural circuits for control of mood, thought, Neural circuits for control of mood, thought,
sleep, appetite, and behavior are dysregulated.sleep, appetite, and behavior are dysregulated. Depression results from influence of multiple Depression results from influence of multiple
genes acting together with environmental genes acting together with environmental factors.factors.
Depressive symptoms are associated with Depressive symptoms are associated with ovarian hormone fluctuation, but there is no ovarian hormone fluctuation, but there is no relationship between serum levels and relationship between serum levels and depressed mooddepressed mood
Affected woman have enhanced neurobiological Affected woman have enhanced neurobiological sensitivity to hormonal fluctuation.sensitivity to hormonal fluctuation.
Most women do not experience significant Most women do not experience significant mood problems during reproductive transitions.mood problems during reproductive transitions.
1414
Evidence Based Interventions: Evidence Based Interventions: PsychotherapyPsychotherapy
Several types of short-term (8-16 sessions, Several types of short-term (8-16 sessions, focused psychotherapy)focused psychotherapy)
Patient choice, access, depression severity Patient choice, access, depression severity Interpersonal Psychotherapy targets Interpersonal Psychotherapy targets
interpersonal distress and effect on mood interpersonal distress and effect on mood www.apa.org/divisions/div12/rev_est/ipt_depr.htmlwww.apa.org/divisions/div12/rev_est/ipt_depr.html
Cognitive Behavior Therapy – correct distorted Cognitive Behavior Therapy – correct distorted and dysfunctional automatic thoughtsand dysfunctional automatic thoughtswww.beckinstitute.org/what-is-cognitive-behavioral-www.beckinstitute.org/what-is-cognitive-behavioral-therapytherapy
Dialectical Behavior Therapy--combines Dialectical Behavior Therapy--combines standard CBT techniques with skill building - standard CBT techniques with skill building - distress tolerance, acceptance, mindfulnessdistress tolerance, acceptance, mindfulnesshttp://behavioraltech.org/index.cfmhttp://behavioraltech.org/index.cfm
1515
All Antidepressants have Similar All Antidepressants have Similar EfficacyEfficacy Serotonergic (SSRI-sertraline, Serotonergic (SSRI-sertraline, fluoxetine; SNRI, venlafaxine)fluoxetine; SNRI, venlafaxine)• Comorbid Obsessive-compulsive disorderComorbid Obsessive-compulsive disorder• Hot flashesHot flashes• Side effects=Sexual dysfunction, weight gain, Side effects=Sexual dysfunction, weight gain,
nausea/ diarrhea, sleep disturbance, apathynausea/ diarrhea, sleep disturbance, apathyNorepinephrine (Tricyclics-Norepinephrine (Tricyclics-
nortriptyline, SNRI)nortriptyline, SNRI)• Serum level is meaningfulSerum level is meaningful• Side effects=Tremor, tachycardia, dry mouth, Side effects=Tremor, tachycardia, dry mouth,
insomnia, weight gaininsomnia, weight gain
Dopamine/Norepinephrine (bupropion)Dopamine/Norepinephrine (bupropion)• Smoking cessation Smoking cessation • Side effects=Agitation, psychosis, weight Side effects=Agitation, psychosis, weight
neutral/ appetite suppressionneutral/ appetite suppression
Personalize Antidepressant Personalize Antidepressant Choice Choice
1616
Perimenopausal Depression Treatment
Antidepressants and Psychotherapy first line Antidepressants and Psychotherapy first line Transdermal estradiol (E2), small RCTs positiveTransdermal estradiol (E2), small RCTs positive
•3-12 wk RCTs of E3-12 wk RCTs of E2 2 50-100 ug/d) vs Placebo50-100 ug/d) vs Placebo•68-80% response of E68-80% response of E22 vs 20% to Placebo vs 20% to Placebo
JJoffe et al, N=72offe et al, N=72•8 wk RCT E2 (50 ug/day), zolpidem, Placebo8 wk RCT E2 (50 ug/day), zolpidem, Placebo•Similar improvement across 3 groupsSimilar improvement across 3 groups
Morrison et al, N=72Morrison et al, N=72•E2 (100 mcg/day) E2 (100 mcg/day) notnot efficacious compared efficacious compared to PL after 8 weeks in to PL after 8 weeks in older older (mean=62 years) (mean=62 years) post-menopausal women post-menopausal women •For E2 treatment: STRAW -1 to +1a and 1bFor E2 treatment: STRAW -1 to +1a and 1b
Post-meno. women respond more favorably to Post-meno. women respond more favorably to tricyclics (nortriptyline) than to SSRItricyclics (nortriptyline) than to SSRI
1717
Estradiol Treatment Complex relationship between gonadal hormones and Complex relationship between gonadal hormones and
depression depression Not a hormone deficiency: Levels of FSH and E2 do not Not a hormone deficiency: Levels of FSH and E2 do not
distinguish women with/ without depressiondistinguish women with/ without depression Response to E2 is not predicted by baseline or post-Response to E2 is not predicted by baseline or post-
treatment E2 levelstreatment E2 levels E2 has antidepressant properties E2 has antidepressant properties The mood enhancing effects of E2 occurs independent The mood enhancing effects of E2 occurs independent
of the presence of hot flashesof the presence of hot flashes SSRI/SNRI reduce vasomotor symptoms, but not as SSRI/SNRI reduce vasomotor symptoms, but not as
effective as E2effective as E2
Environmental Approaches
Aerobic Exercise (> 30 minutes of moderate intensity physical exercise, 3 to 5 days per week) Dunn et al, Am J Prev Med 2005;28:1-8, 2005
Nutritional status; Vitamin D . EMAS position statement: Vitamin D and postmenopausal healthPerez-Lopez et al, Maturitas 71:83-88, 2012
Essential Fatty Acids for Cardiac Health/ Depression/ Immune Function
1-2 grams of EFA/day as in AHA recommendations; Reviews: Freeman et al. J Clin Psych 67, 2006; Parker et al, Am J Psych 163:969-978, 2006
Bright Morning Light Therapy Bright Morning Light
Therapy, 10,000 lux commercial UV blocked box
Center for Environmental Therapeutics, tools at www.cet.org APA review and meta-analysis- Am J Psych 162:656-662, 2005
Data support efficacy in non-seasonal depression: a non-pharmacologic somatic RX for depression
2020
WARNING!WARNING!
Insufficient Medical ResearchInsufficient Medical ResearchCan be HazardousCan be Hazardous to your Health to your Health
C. Everett Koop, M.D.C. Everett Koop, M.D.